Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users

Effects of Helicobacter pylori Infection on Long-term Risk of Peptic Ulcer Bleeding in Low-Dose Aspirin Users

(2013) Francis K.L. Chan et al.   GASTROENTEROLOGY

Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: Implications for clinical practice

(2012) En-ling Leung Ki et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Gastrointestinal effects of aspirin

(2011) Carlos Sostres et al.   Nature Reviews Gastroenterology & Hepatology

Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin

(2010) E. H. Fletcher et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice

(2010) Angel Lanas   Expert Opinion On Drug Safety

Peptic ulcer disease

(2009) Peter Malfertheiner et al.   LANCET

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

(2008) Deepak L. Bhatt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY